Effectiveness of intravascular lithotripsy followed by drug-coated balloon angioplasty for the treatment of undilatable calcified in-sent neoatherosclerosis

血管内碎石联合药物涂层球囊血管成形术治疗不可扩张的钙化性新生动脉粥样硬化的疗效

阅读:1

Abstract

Although intravascular lithotripsy (IVL) has been introduced as an effective method for treating severely calcified native coronary artery lesions, its use in in-stent restenosis (ISR) lesions is still off-label. We report a 71-year-old man with a previous percutaneous coronary intervention (PCI) to the left circumflex coronary artery (LCX) who was readmitted for ST-segment elevation myocardial infarction. Coronary angiography showed a total occlusion at the middle portion of the first diagonal branch, a significant stenosis in the proximal left anterior descending coronary artery, and a diffuse significant stenosis including ISR of the previously stented segment in the proximal to mid LCX. The occluded culprit lesion of the diagonal branch was successfully reperfused. Optical frequency domain imaging during staged PCI for the LCX lesion revealed severe calcified in-stent neoatherosclerosis. Multiple dilatations with balloons all failed. Thus, IVL was successfully used to modify the underlying calcified neointima. Two drug-coated balloons were then utilized to cover the whole stenotic segment with optimal lumen gain. One year later, the patient remains event-free. LEARNING OBJECTIVES: Although the use of intravascular lithotripsy (IVL) for in-stent restenosis (ISR) remains an off-label indication, this case indicates that the combination of IVL and drug-coated balloon angioplasty may represent an effective treatment strategy for calcified ISR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。